Liu, Y., Liu, P., Song, Y., Li, S., Shi, Y., Quan, K., . . . Zhu, W. (2021). A heparin–rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis. BMC.
Chicago Style (17th ed.) CitationLiu, Yingjun, et al. A Heparin–rosuvastatin-loaded P(LLA-CL) Nanofiber-covered Stent Inhibits Inflammatory Smooth-muscle Cell Viability to Reduce In-stent Stenosis and Thrombosis. BMC, 2021.
MLA (9th ed.) CitationLiu, Yingjun, et al. A Heparin–rosuvastatin-loaded P(LLA-CL) Nanofiber-covered Stent Inhibits Inflammatory Smooth-muscle Cell Viability to Reduce In-stent Stenosis and Thrombosis. BMC, 2021.
Warning: These citations may not always be 100% accurate.